Breakthrough research throughout Mass General Brigham—including the Massachusetts General Hospital, Brigham and Women’s Hospital, McLean Hospital, and Spaulding Rehabilitation Network – is redefining how healthcare is delivered. From neuroinformatic analysis of big data to cutting-edge gene-editing technology, the research in progress at Mass General Brigham is truly game-changing.

Mass General Brigham innovators are finding ways to prevent, halt, and defeat neurological diseases ranging from Alzheimer’s to multiple sclerosis. For example, Rudy Tanzi, PhD, the Joseph P. and Rose F. Kennedy Professor of Child Neurology at MGH made worldwide headlines in 2014 with his “Alzheimer’s-in-a-dish” approach that replaces mouse models with a 3-D culture system. In addition to breakthroughs in Alzheimer’s disease, Mass General Brigham covers the vast spectrum of Neurological disorders from autism and depression to schizophrenia and everything in between.